Show simple item record

dc.creatorKoprivica, Ivan
dc.creatorStanisavljević, Suzana
dc.creatorMićanović, Dragica
dc.creatorJevtić, Bojan
dc.creatorStojanović, Ivana D.
dc.creatorMiljković, Đorđe
dc.date.accessioned2023-11-10T12:44:02Z
dc.date.available2023-11-10T12:44:02Z
dc.date.issued2023
dc.identifier.issn1664-3224
dc.identifier.urihttp://radar.ibiss.bg.ac.rs/handle/123456789/6294
dc.description.abstractInnate lymphoid cells type 3 (ILC3s) are the first line sentinels at the mucous tissues, where they contribute to the homeostatic immune response in a major way. Also, they have been increasingly appreciated as important modulators of chronic inflammatory and autoimmune responses, both locally and systemically. The proper identification of ILC3 is of utmost importance for meaningful studies on their role in immunity. Flow cytometry is the method of choice for the detection and characterization of ILC3. However, the analysis of ILC3-related papers shows inconsistency in ILC3 phenotypic definition, as different inclusion and exclusion markers are used for their identification. Here, we present these discrepancies in the phenotypic characterization of human and mouse ILC3s. We discuss the pros and cons of using various markers for ILC3 identification. Furthermore, we consider the possibilities for the efficient isolation and propagation of ILC3 from different organs and tissues for in-vitro and in-vivo studies. This paper calls upon uniformity in ILC3 definition, isolation, and propagation for the increased possibility of confluent interpretation of ILC3’s role in immunity.sr
dc.language.isoensr
dc.publisherLausanne: Frontiers Media SAsr
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200007/RS//sr
dc.relationinfo:eu-repo/grantAgreement/ScienceFundRS/Ideje/7742898/RS//sr
dc.rightsopenAccesssr
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceFrontiers in Immunologysr
dc.subjectinnate lymphoid cellssr
dc.subjectphenotypesr
dc.subjectflow cytometrysr
dc.subjecthumanssr
dc.subjectmicesr
dc.titleILC3: a case of conflicted identitysr
dc.typearticlesr
dc.rights.licenseBYsr
dc.rights.holder© 2023 Koprivica, Stanisavljević, Mićanović, Jevtić, Stojanović and Miljkovićsr
dc.citation.volume14
dc.identifier.doi10.3389/fimmu.2023.1271699
dc.identifier.pmid37915588
dc.identifier.scopus2-s2.0-85175543983
dc.citation.apaKoprivica, I., Stanisavljević, S., Mićanović, D., Jevtić, B., Stojanović, I., & Miljković, Đ. (2023). ILC3: a case of conflicted identity. Frontiers in Immunology, 14, 1271699.
dc.citation.vancouverKoprivica I, Stanisavljević S, Mićanović D, Jevtić B, Stojanović I, Miljković Đ. ILC3: a case of conflicted identity. Front Immunol. 2023;14:1271699.
dc.citation.spage1271699
dc.type.versionpublishedVersionsr
dc.identifier.fulltexthttps://radar.ibiss.bg.ac.rs/bitstream/id/15655/bitstream_15655.pdf
dc.citation.rankM21~


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record